Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Yupelri for maintenance treatment of COPD

Nov. 12, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

FDA approves Bijuva for moderate to severe hot flashes due to menopause

Oct. 30, 2018

France becomes first country to market baclofen preparation to reduce alcohol consumption

Oct. 29, 2018

FDA approves Dupixent as add-on maintenance therapy for asthma

Oct. 22, 2018

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

Oct. 17, 2018

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Oct. 15, 2018

Revcovi approved in U.S. for ADA-SCID

Oct. 8, 2018

FDA approves Nuzyra for CABP and ABSSSI

Oct. 3, 2018

FDA approves Seysara for acne

Oct. 3, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...